Status:
COMPLETED
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
Lead Sponsor:
Wayne Sullender, M.D.
Collaborating Sponsors:
All India Institute of Medical Sciences
Centers for Disease Control and Prevention
Conditions:
Influenza
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The study described here will immunize children with trivalent influenza vaccine (TIV) and determine whether this reduces influenza illness among the immunized children and their older family members....
Detailed Description
Influenza is an important cause of illness among children and adults in the United States. Influenza is likely also an important cause of illness in India, but published data on influenza infections i...
Eligibility Criteria
Inclusion
- Inclusion in either vaccine group (TIV or IPV) will require ages 6 months through 10 years of age.
- All individuals in enrolled households will be eligible for enrollment into surveillance arm.
Exclusion
- Exclusion criteria from the vaccine groups includes known allergy to eggs, or hypersensitivity to other components of a vaccine (streptomycin, neomycin, and polymyxin B)
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
4598 Patients enrolled
Trial Details
Trial ID
NCT00934245
Start Date
September 1 2009
End Date
July 1 2012
Last Update
February 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Rural Health Services Project (CRHSP)
Ballabgarh, Haryana, India